By proceeding, you agree to our Terms of Use and Privacy Policy.
The 3rd Annual iPSC Derived-Cell Therapies Summit invites all those interested in the iPSC space to join and share their knowledge and experience in discovery, translation, and clinical strategy. This event aims to unite peers to identify current bottlenecks and showcase the pre-clinical and clinical landscape. Attendees will have the opportunity to discuss strategies and progress quickly through the clinic while navigating uncertainties and leveraging the investment landscape.The summit will provide a platform for attendees to hear clinical data, discuss the future of iPSCs in oncology and regenerative medicine, and learn from lessons learned. It will also offer creative approaches to enhance investment appeal, streamline clinical pipelines, and improve the safety and approval of iPSC-derived products for currently untreatable diseases.Join us and be a part of this collaborative effort to accelerate clinical proof of concept and shape the future of cell therapy and regenerative medicine.
Uncover the top service providers partnering to solve your preclinical and clinical needs.
Enhance your knowledge in reaffirming the future of IPSC-derived cell therapies and improve clinical translational strategies to streamline clinical success.
Get into the interactive sessions and discussions by top industry experts to discuss the future of iPSCs across oncology and regenerative medicine.
Take home creative approaches to elevate investment appeal & clinical pipeline and enhance your iPSC-derived product to cure currently untreatable diseases.
18-19 April 2024
Join us at the MarketsandMarkets High Potent Medicines Conference, taking place on 19th - 20th October 2023, in Boston, USA. This groundbreaking conference is designed to address the emerging trends and challenges in the high potent medicines market.
Event Started
USA
Paid
Boston
Hanson Wade gives people the clarity to see where opportunity lies. We work in highly specialised fields to provide unmatched depth and quality of content. We work in sectors where quality of information is the difference between success and failure.
Catalent is a global leader in providing integrated services, superior delivery technologies, and manufacturing solutions to help life science innovators develop and launch successful pharmaceuticals, biologics, and consumer health products
At Lonza, we enable #AHealthierWorld by supporting our healthcare customers on the path to commercialization.
Cellino is on a mission to make personalized, autologous cell therapies accessible for patients.
PBS Biotech, Inc. in Camarillo, CA designs & manufactures the industry's most advanced single-use bioreactors and disposable vessels and bags.
Cell Microsystems develops, manufactures, and markets innovative products for single cell biology.
Stem Genomics provides dedicated services to assess the genetic integrity of human stem cells. We help research scientists with specific assays and recommended workflows for the cell type they work with. Our flagship testing solution, iCS-digital™ PS
Stem Genomics provides dedicated services to assess the genetic integrity of human stem cells. We help research scientists with specific assays and recommended workflows for the cell type they work with. Our flagship testing solution, iCS-digital™ PSC, has revolutionized in-process genomic stability
All trademarks, registered trademarks, product names, and company names or logos mentioned in or on this site are the property of their respective owners.
A great community. Legit content. The kind of emails you actually look forward to.